In Silico Design of a Trans-Amplifying RNA-Based Vaccine against SARS-CoV-2 Structural Proteins

Nucleic acid-based vaccines allow scalable, rapid, and cell-free vaccine production in response to an emerging disease such as the current COVID-19 pandemic. Here, we objected to the design of a multiepitope mRNA vaccine against the structural proteins of SARS-CoV-2. Through an immunoinformatic appr...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatemeh Nafian, Ghazal Soleymani, Zahra Pourmanouchehri, Mahnaz Kiyanjam, Simin Nafian, Sayed Mohammad Mohammadi, Hanie Jeyroudi, Sharareh Berenji Jalaei, Fatemeh Sabzpoushan
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2024/3418062
Tags: Add Tag
No Tags, Be the first to tag this record!